Analysts’ Viewpoint on Breast Tissue Markers Market Scenario
Rise in number of breast cancer cases has compelled governments across the world to spread awareness about the importance of early detection of breast cancer. This is expected to drive global breast tissue markers market size in the next few years. Breast tissue markers give the surgeon an advantage in identifying and marking the biopsy area with a physical tag, allowing him to diagnose and operate more effectively. A standard stainless steel marker is used in the traditional method. More advanced breast tissue markers, such as partially bio-absorbable and mineral-based markers, are used to ensure complete patient satisfaction. Key players in the market are launching new tissue marker breast biopsy products to enhance their market share. Increase in adoption of tissue markers is likely to augment the global breast tissue markers market growth in the near future.
Breast tissue markers are commonly used in mammography diagnostic imaging. Typically, these are implanted just after a percutaneous biopsy under ultrasonic or stereotactic guidelines. On follow-up imaging, these can be extremely helpful in identifying relatively harmless regions or shrinking/treated malignant lesions. Breast tissue markers are now available in various shapes, compositions, and partially bio-absorbable components. Ribbon, coil, and wing markers with easily distinguishable appearances on mammograms are among the makers currently in use. New ultrasound-detectable markers are also available in the market. Breast tissue markers can be used to guide subsequent radiotherapy treatments with clips inserted prior to surgery (localization wire targets).
Request a sample to get extensive insights into the Breast Tissue Markers Market
In a biopsy procedure, a metal clip with a 3 mm diameter is commonly used as a radio marker so that the lesion can be clearly identified on subsequent imaging inspection. A metal clip marker remains in the breast indefinitely. This is a significant disadvantage. Therefore, most women refuse to have a biopsy. This is exacerbated when a patient has had numerous breast biopsies and much more than a metal clip marker is implanted to differentiate abnormal lesions on a mammography. Furthermore, metal clips migrate away from the biopsy insertion site after deployment. Another disadvantage of metal markers is that they cause issues during MRI because of changes in the local magnetic field caused by the implants' ferromagnetic, paramagnetic, and diamagnetic properties. This could reduce MRI's sensitivity for breast cancer detection and treatment monitoring. Therefore, biodegradable breast tissue markers are being developed as implants in the breast biopsy market. These biodegradable breast biopsy markers have the potential to serve as visual markers for breast tumor growth regions for the required follow-up period, such as six months, before being completely eliminated from the body.
Regional government authorities are launching breast cancer awareness and screening programs to reduce the mortality rates associated with breast cancer. Breast cancer therapeutics are becoming more effective in the treatment of the disease, with more than 90% survival probabilities, especially when the disease is detected early. According to the World Health Organization, around 2.3 million new cases of breast cancer and 685,000 deaths were recorded globally in 2020. Breast cancer has been diagnosed in 7.8 million women in the previous five years ending 2020, making it the world's most common cancer.
Initiation of breast cancer awareness campaigns by public organizations is expected to encourage breast cancer learning and breast cancer therapeutic applications. The National Breast Cancer Foundation launched ‘October as Breast Cancer Awareness Month,’ a campaign to increase awareness about the dangers of breast cancer. Such efforts are expected to encourage recently diagnosed breast cancer patients, thereby driving the global market.
Request a custom report on Breast Tissue Markers Market
Breast biopsies are typically used to diagnose breast cancer, but these can also be used to screen for other diseases discovered during a physical examination. Breast biopsies are commonly performed using fine needle aspiration biopsy, which is one of the least invasive procedures available. It also does not leave any scarring. A needle is inserted through the dermal tissue of the breast to remove tissue. Another technique, known as stereotactic needle biopsy in combination with a mammogram, guides this same biopsy with ultrasound radiation. The ultrasound tracker directs the needle to the chosen place in the breast during treatment. Stereotactic mammography is a method that employs images taken from different vantage points to identify the site of a malignant tumor in addition to the placement of the needle used to acquire a breast biopsy sample. Thus, breast marker is a small titanium or stainless steel marker the size of a sesame seed. Breast biopsy markers are used to pinpoint the location of the breast tissue removed during a biopsy procedure.
In terms of product, the global breast tissue markers market has been classified into coil, ribbon, bowtie, butterfly, bowtie, U shape, and others. Coil breast tissue markers are commonly used in partially biodegradable breast tissue markers. These breast tissue markers help a surgeon diagnose and operate more effectively by identifying and marking the biopsy area with a physical tag. Furthermore, mergers and acquisitions are projected to drive the coil segment in the near future. For instance, Mammotome announced the launch of a new product line of flexible HydroMARK Breast Biopsy Site Marker applicators designed to improve the clinician's user experience. The new applicator line expands compatibility with leading vacuum-assisted breast biopsy systems, bringing the HydroMARK markers to more customers in more clinical settings.
Based on material, the global breast tissue markers market has been bifurcated into partially biodegradable and non-biodegradable. Non-biodegradable clips are made up of titanium, with no absorbable PVA polymer pellet or other materials. Titanium is widely used in breast tissue markers. The breast tissue markers market is focusing on end-user education and training. Several companies operating in the global market are providing their products at reasonable prices.
In terms of end-user, the global breast tissue markers market has been divided into hospitals, ambulatory surgical centers, diagnostic centers, and specialty clinics. Increasing number of patients are seeking hospitals that provide patient-centered care. In other words, these hospitals establish a reputation of offering patients high-quality care, giving them a competitive edge over institutions that continue to rely on outdated practices. Overall decrease in hospital care expenses is also projected to drive the hospitals segment during the forecast period.
North America accounted for major share of around 40.0% of the global breast tissue markers market in 2021. According to the breast tissue markers market forecast, the region is anticipated to dominate the global breast tissue markers market in the next few years owing to the presence of major players, established diagnostic & screening infrastructure, technological advancements, high patient awareness, and favorable reimbursement policies. The prevalence of breast cancer is rising in North America. This has increased the usage of advanced diagnostic techniques in the region. The market in North America is expected to be driven by expanding healthcare infrastructure and favorable reimbursement policies in the region. Increase in disposable income, rapid urbanization, improved health care infrastructure, and distribution and partnership strategies adopted by key players are also propelling the market in the region.
The breast tissue markers market in Asia Pacific is expected to grow at the fastest CAGR during the forecast period due to the surge in incidence of breast cancer and adoption of advanced diagnostic techniques in the region. Furthermore, rise in healthcare infrastructure and improving reimbursement guidelines are likely to augment the market in Asia Pacific.
The global breast tissue markers market is consolidated, with the presence of a small number of leading players. Most of the companies are investing significantly in R&D activities, primarily to introduce advanced breast tissue markers such as BioZorb tissue markers. Key players are engaging in strategic alliances to increase revenue and market share. Furthermore, diversification of product portfolios and mergers & acquisitions are the major strategies adopted by the players. Mammotome, BD, Hologic, Inc., Carbon Medical Technologies, Inc., Scion Medical Technologies, LLC, Mermaid Medical, and SOMATEX Medical Technologies GmbH are prominent players operating in the global breast tissue markers market.
Each of these players has been profiled in the breast tissue markers market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 2.5 Bn |
|
Market Forecast Value in 2031 |
More than US$ 5.8 Bn |
|
Growth Rate (CAGR) |
8.3% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global breast tissue markers market was valued at US$ 2.5 Bn in 2021
The global breast tissue markers market is projected to reach more than US$ 5.8 Bn by 2031
The global breast tissue markers market is anticipated to grow at a CAGR of 8.3% from 2022 to 2031
Rise in number of breast cancer cases is driving the global breast tissue markers market
The non-biodegradable segment held more than 57% share of the global breast tissue markers market in 2021
Mammotome, BD, Hologic, Inc., Carbon Medical Technologies, Inc., Scion Medical Technologies, LLC, Mermaid Medical, and SOMATEX Medical Technologies GmbH
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Breast Tissue Markers Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Breast Tissue Markers Market Analysis and Forecast, 2017 - 2031
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Key product/brand Analysis
5.2. Pipeline Analysis
5.3. Side Effects of Breast Tissue Markers
5.4. Patents
5.5. Key Mergers & Acquisitions
5.6. Pricing Analysis
5.7. Application of Clip Markers (outside mammography)
5.8. Breast Tissue Markers used per case
5.9. Disease Prevalence & Incidence Rate globally with key countries
5.10. COVID 19 Impact Analysis
6. Global Breast Tissue Markers Market Analysis and Forecast, By Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Coil
6.3.2. Ribbon
6.3.3. Bowtie
6.3.4. Butterfly
6.3.5. Wing
6.3.6. U Shape
6.3.7. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Breast Tissue Markers Market Analysis and Forecast, By Material
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market ValueForecast, by Material, 2017 - 2031
7.3.1. Non-biodegradable
7.3.2. Partially Biodegradable
7.4. Market Attractiveness Analysis, by Material
8. Global Breast Tissue Markers Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Diagnostic Centers
8.3.4. Specialty Clinics
8.4. Market Attractiveness Analysis, by End-user
9. Global Breast Tissue Markers Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
10. North America Breast Tissue Markers Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017 - 2031
10.2.1. Coil
10.2.2. Ribbon
10.2.3. Bowtie
10.2.4. Butterfly
10.2.5. Wing
10.2.6. U shape
10.2.7. Others
10.3. Market Value Forecast, by Material, 2017 - 2031
10.3.1. Non-biodegradable
10.3.2. Partially Biodegradable
10.4. Market Value Forecast, by End-user, 2017 - 2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Diagnostic Centers
10.4.4. Specialty Clinics
10.5. Market Value Forecast, by Country, 2017 - 2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Material
10.6.3. By End-user
10.6.4. By Country
11. Europe Breast Tissue Markers Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017 - 2031
11.2.1. Coil
11.2.2. Ribbon
11.2.3. Bowtie
11.2.4. Butterfly
11.2.5. Wing
11.2.6. U shape
11.2.7. Others
11.3. Market Value Forecast, by Material, 2017 - 2031
11.3.1. Non-biodegradable
11.3.2. Partially Biodegradable
11.4. Market Value Forecast, by End-user, 2017 - 2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Diagnostic Centers
11.4.4. Specialty Clinics
11.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Material
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Latin America Breast Tissue Markers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017 - 2031
12.2.1. Coil
12.2.2. Ribbon
12.2.3. Bowtie
12.2.4. Butterfly
12.2.5. Wing
12.2.6. U shape
12.2.7. Others
12.3. Market Value Forecast, by Material, 2017 - 2031
12.3.1. Non-biodegradable
12.3.2. Partially Biodegradable
12.4. Market Value Forecast, by End-user, 2017 - 2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Diagnostic Centers
12.4.4. Specialty Clinics
12.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By Degree of Cooling
12.6.4. By Country/Sub-region
13. Middle East & Africa Breast Tissue Markers Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017 - 2031
13.2.1. Coil
13.2.2. Ribbon
13.2.3. Bowtie
13.2.4. Butterfly
13.2.5. Wing
13.2.6. U shape
13.2.7. Others
13.3. Market Value Forecast, by Material, 2017 - 2031
13.3.1. Non-biodegradable
13.3.2. Partially Biodegradable
13.4. Market Value Forecast, by End-user, 2017 - 2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Diagnostic Centers
13.4.4. Specialty Clinics
13.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By Degree of Cooling
13.6.4. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2018
14.3. Company Profiles
14.3.1. Mammotome
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Company Financials
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. BD
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Company Financials
14.3.2.3. Growth Strategies
14.3.2.4. SWOT Analysis
14.3.3. Hologic, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Company Financials
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. Carbon Medical Technologies, Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Company Financials
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. Scion Medical Technologies, LLC
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Company Financials
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. Mermaid Medical
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Company Financials
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. SOMATEX Medical Technologies GmbH
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Company Financials
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis
List of Tables
Table 01: Global Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031
Table 03: Global Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Breast Tissue Markers Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 07: North America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031
Table 08: North America Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Breast Tissue Markers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 11: Europe Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031
Table 12: Europe Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Breast Tissue Markers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Asia Pacific Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031
Table 16: Asia Pacific Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 19: Latin America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031
Table 20: Latin America Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Breast Tissue Markers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 23: Middle East & Africa Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031
Table 24: Middle East & Africa Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 1: Global Breast Tissue Markers Market, by Product, 2021 and 2031
Figure 2: Global Breast Tissue Markers Market Attractiveness Analysis, by Product, 2022–2031
Figure 3: Global Breast Tissue Markers Market (US$ Mn), by Coil, 2017–2031
Figure 4: Global Breast Tissue Markers Market (US$ Mn), by Ribbon, 2017–2031
Figure 5: Global Breast Tissue Markers Market (US$ Mn), by Bowtie, 2017–2031
Figure 6: Global Breast Tissue Markers Market (US$ Mn), by Butterfly, 2017–2031
Figure 7: Global Breast Tissue Markers Market (US$ Mn), by Wing, 2017–2031
Figure 8: Global Breast Tissue Markers Market (US$ Mn), by U shape, 2017–2031
Figure 9: Global Breast Tissue Markers Market (US$ Mn), by Others, 2017–2031
Figure 10: Global Breast Tissue Markers Market, by Material, 2021 and 2031
Figure 11: Global Breast Tissue Markers Market Attractiveness Analysis, by Product, 2022–2031
Figure 12: Global Breast Tissue Markers Market (US$ Mn), by Partially Biodegradable, 2017–2031
Figure 13: Global Breast Tissue Markers Market (US$ Mn), by Non-biodegradable, 2017–2031
Figure 14: Global Breast Tissue Markers Market, by End-user, 2021 and 2031
Figure 15: Global Breast Tissue Markers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 16: Global Breast Tissue Markers Market (US$ Mn), by Hospitals, 2017–2031
Figure 17: Global Breast Tissue Markers Market (US$ Mn), by Ambulatory Surgical Centers, 2017–2031
Figure 18: Global Breast Tissue Markers Market (US$ Mn), by Diagnostic Centers, 2017–2031
Figure 19: Global Breast Tissue Markers Market (US$ Mn), by Specialty Clinics, 2017–2031
Figure 20: Global Breast Tissue Markers Market Value Share Analysis, by Region, 2021 and 2031
Figure 21: Global Breast Tissue Markers Market Attractiveness Analysis, by Region, 2022–2031
Figure 22: North America Breast Tissue Markers Market Value (US$ Mn) Forecast, 2017–2031
Figure 23: North America Breast Tissue Markers Market Value Share Analysis, by Country, 2021 and 2031
Figure 24: North America Breast Tissue Markers Market Attractiveness Analysis, by Country, 2022–2031
Figure 25: North America Breast Tissue Markers Market, by Product, 2021 and 2031
Figure 26: North America Breast Tissue Markers Market Attractiveness Analysis, by Product, 2022–2031
Figure 27: North America Breast Tissue Markers Market, by Material, 2021 and 2031
Figure 28: North America Breast Tissue Markers Market Attractiveness Analysis, by Material, 2022–2031
Figure 29: North America Breast Tissue Markers Market, by End-user, 2021 and 2031
Figure 30: North America Breast Tissue Markers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 31: Europe Breast Tissue Markers Market Value (US$ Mn) Forecast, 2017–2031
Figure 32: Europe Breast Tissue Markers Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 33: Europe Breast Tissue Markers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 34: Europe Breast Tissue Markers Market, by Product, 2021 and 2031
Figure 35: Europe Breast Tissue Markers Market Attractiveness Analysis, by Product, 2022–2031
Figure 36: Europe Breast Tissue Markers Market, by Material, 2021 and 2031
Figure 37: Europe Breast Tissue Markers Market Attractiveness Analysis, by Material, 2022–2031
Figure 38: Europe Breast Tissue Markers Market, by End-user, 2021 and 2031
Figure 39: Europe Breast Tissue Markers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 40: Asia Pacific Breast Tissue Markers Market Value (US$ Mn) Forecast, 2017–2031
Figure 41: Asia Pacific Breast Tissue Markers Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 42: Asia Pacific Breast Tissue Markers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 43: Asia Pacific Breast Tissue Markers Market, by Product, 2021 and 2031
Figure 44: Asia Pacific Breast Tissue Markers Market Attractiveness Analysis, by Product, 2022–2031
Figure 45: Asia Pacific Breast Tissue Markers Market, by Material, 2021 and 2031
Figure 46: Asia Pacific Breast Tissue Markers Market Attractiveness Analysis, by Material, 2022–2031
Figure 47: Asia Pacific Breast Tissue Markers Market, by End-user, 2021 and 2031
Figure 48: Asia Pacific Breast Tissue Markers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 49: Latin America Breast Tissue Markers Market Value (US$ Mn) Forecast, 2017–2031
Figure 50: Latin America Breast Tissue Markers Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 51: Latin America Breast Tissue Markers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 52: Latin America Breast Tissue Markers Market, by Product, 2021 and 2031
Figure 53: Latin America Breast Tissue Markers Market Attractiveness Analysis, by Product, 2022–2031
Figure 54: Latin America Breast Tissue Markers Market, by Material, 2021 and 2031
Figure 55: Latin America Breast Tissue Markers Market Attractiveness Analysis, by Material, 2022–2031
Figure 56: Latin America Breast Tissue Markers Market, by End-user, 2021 and 2031
Figure 57: Latin America Breast Tissue Markers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 58: Middle East & Africa Breast Tissue Markers Market Value (US$ Mn) Forecast, 2017–2031
Figure 59: Middle East & Africa Breast Tissue Markers Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 60: Middle East & Africa Breast Tissue Markers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 61: Middle East & Africa Breast Tissue Markers Market, by Product, 2021 and 2031
Figure 62: Middle East & Africa Breast Tissue Markers Market Attractiveness Analysis, by Product, 2022–2031
Figure 63: Middle East & Africa Breast Tissue Markers Market, by Material, 2021 and 2031
Figure 64: Middle East & Africa Breast Tissue Markers Market Attractiveness Analysis, by Material, 2022–2031
Figure 65: Middle East & Africa Breast Tissue Markers Market, by End-user, 2021 and 2031
Figure 66: Middle East & Africa Breast Tissue Markers Market Attractiveness Analysis, by End-user, 2022–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Breast Tissue Markers Market
